- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£222.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£143.18
7D
7.7%
1Y
41.5%
Gilead Sciences
Market Cap: US$158.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$127.88
7D
2.4%
1Y
15.3%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,548.00
7D
0.3%
1Y
0.3%
Orion Oyj
Market Cap: €9.9b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€70.00
7D
2.2%
1Y
9.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥42.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥107.01
7D
25.2%
1Y
15.0%
Xiamen Amoytop Biotech
Market Cap: CN¥21.6b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥55.40
7D
3.0%
1Y
-23.2%
PharmaResearch
Market Cap: ₩3.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩349,000.00
7D
18.9%
1Y
-29.3%